Healthcare Innovation August 20, 2024
Amit Kapoor, M.D., M.B.A., chief nephrology officer at Strive Health, discusses recent JAMA Health Forum study that shows little impact on home dialysis or transplant rates
A recent JAMA Health Forum study found that the Centers for Medicare & Medicaid Services’ End-Stage Renal Disease Treatment Choices (ETC) alternative payment model showed no statistically significant impact on the use of home dialysis or kidney transplant rates. Healthcare Innovation recently discussed the study with Amit Kapoor, M.D., chief nephrologist at Strive Health, a value-based care company focused on kidney disease.
Healthcare Innovation: Before we start talking about CMS’ ETC model and this study, could you describe your background and role at Strive?
Kapoor: I am a board-certified, practicing nephrologist. I...
Today's Sponsors
Today's Sponsor